Stay updated on Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial

Sign up to get notified when there's something new on the Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The record history now shows a new revision entry v3.6.6, replacing the previous v3.6.5 entry. This updates the study's revision history to reflect a latest change to the record.
    Difference
    0.1%
    Check dated 2026-08-29T20:19:38.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    A new version entry (32) was added to the Record History, introducing Contacts/Locations and Study Status sections for the study record. This updates how changes to the record are tracked and displayed.
    Difference
    0.4%
    Check dated 2026-08-22T22:20:27.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    A new revision tag v3.6.5 was added to the record history, replacing the previous v3.6.4, indicating an updated version of the study record. This change updates the record's metadata rather than trial data or outcomes.
    Difference
    0.1%
    Check dated 2026-08-08T20:27:48.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The study record's revision history gains a new entry for v3.6.4 and removes the previous v3.6.3 entry, indicating an update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-07-25T13:16:38.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    A new revision entry, v3.6.3, was added to the record history. The previous revision, v3.6.2, was removed from the list.
    Difference
    0.1%
    Check dated 2026-07-03T22:39:55.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    A new revision entry, v3.6.2, was added to the study history and the earlier revision v3.6.0 was removed, updating the historical log displayed on the page.
    Difference
    0.1%
    Check dated 2026-06-26T19:41:39.000Z thumbnail image

Stay in the know with updates to Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial page.